Leemans R, Harms G, Rijkers G T, Timens W
Department of Surgery, Medical Centre, Leeuwarden, The Netherlands.
Clin Exp Immunol. 1999 Sep;117(3):596-604. doi: 10.1046/j.1365-2249.1999.00943.x.
After splenectomy, patients have an increased risk of overwhelming post-splenectomy infection (OPSI) or sepsis involving encapsulated bacteria such as pneumococcus. The value of spleen autotransplantation after splenectomy because of trauma has long been questioned. Much attention has been given to the restoration of mononuclear phagocyte system (MPS) function, which appeared to be similar to that of splenectomized individuals. The presence of specific anti-pneumococcal antibodies may enhance phagocytosis of opsonized bacteria by other parts of the MPS, as present in the liver. Therefore, in the present study we have evaluated the restoration of the humoral immune response after spleen autotransplantation, especially to pneumococcal capsular polysaccharides (PPS). Wistar rats were divided into three groups which were operated as follows: splenectomy, splenectomy followed by autotransplantation, and sham operation. After 12 weeks the rats were vaccinated with 23-valent pneumococcal vaccine. Blood samples were taken after 3 days, 3 and 6 weeks for anti-PPS IgM and IgG ELISA against types 3, 4, 6, 9, 14 and 23. In addition, immunohistological studies were performed on the autotransplants. Significant antibody titre rises were found in a main proportion of the autotransplanted rats, comparable to sham-operated rats. Splenectomized rats showed as well a significantly lower increase in immunoglobulin levels, as significant differences in the proportion of rats showing a minimum two-fold increase of antibody level, considered to represent an adequate response. The titres were highest 3 days after vaccination. Immunohistochemical studies demonstrated structurally functional autotransplants, including an intact marginal zone. Considering this significant anti- pneumococcal antibody response, spleen autotransplants can be expected to enable an improved humoral response to PPS, and to contribute to protection against OPSI after splenectomy.
脾切除术后,患者发生暴发性脾切除术后感染(OPSI)或由肺炎球菌等包膜菌引起的败血症的风险增加。因创伤行脾切除术后自体脾移植的价值长期以来一直受到质疑。单核吞噬细胞系统(MPS)功能的恢复受到了广泛关注,其功能似乎与脾切除个体相似。特异性抗肺炎球菌抗体的存在可能会增强MPS其他部分(如肝脏中的部分)对调理素化细菌的吞噬作用。因此,在本研究中,我们评估了脾自体移植后体液免疫反应的恢复情况,尤其是对肺炎球菌荚膜多糖(PPS)的反应。将Wistar大鼠分为三组,分别进行如下手术:脾切除术、脾切除术后自体移植术和假手术。12周后,给大鼠接种23价肺炎球菌疫苗。在接种后3天、3周和6周采集血样,用于检测针对3、4、6、9、14和23型的抗PPS IgM和IgG ELISA。此外还对自体移植组织进行了免疫组织学研究。在大部分自体移植大鼠中发现抗体滴度显著升高,与假手术大鼠相当。脾切除大鼠的免疫球蛋白水平升高也显著较低,在显示抗体水平至少两倍升高的大鼠比例方面也存在显著差异,这被认为代表了充分的反应。接种疫苗后3天抗体滴度最高。免疫组织化学研究表明自体移植组织在结构上具有功能,包括完整的边缘区。考虑到这种显著的抗肺炎球菌抗体反应,预计脾自体移植能够改善对PPS的体液反应,并有助于预防脾切除术后的OPSI。